SQA 2023: Advancing Quality Assurance in the Life Sciences Industry
Blog At SQA 2023, leaders in the life sciences industry will convene to advance quality assurance practices and promote accurate results and reliable products. SQA is a global non-profit organization committed to developing standards of excellence that help ensure the safety and integrity of scientific research. Through its certification programs, SQA empowers researchers, technicians, managers, […]
Xybion Digital: SQA 2023
Blog Xybion Digital to Showcase its Total Quality and Compliance Management Solutions at SQA 2023 Xybion, a global SaaS company that provides end-to-end unified cloud software solutions for regulated industries, will attend the 39th SQA Annual Meeting in Washington, DC, from March 12-17, 2023. We offer a suite of solutions that can easily be integrated […]
Why do Quantitative and Qualitative Risk Assessments Work Together?
Blog Quantitative and Qualitative Risk Assessments Work Together Did you know that you can use quantitative and qualitative risk assessments to comprehensively understand the potential risks associated with a decision or proposal? Quantitative and qualitative risk assessments work together to help identify and understand risk. This article teaches why combining qualitative and quantitative approaches provides […]
Quality Assurance and Quality Control for Biotech Industries
Blog Quality Assurance and Quality Control Did you know that the global biotech industry is expected to be worth more than $3 trillion by 2030? With a number like that, it isn’t surprising that biotechnology is gathering so much attention. With the ability to affect most areas of our lives, this could soon be the most […]
Pharma QMS: The Key Elements of QMS in Pharmaceuticals
Blog Ensuring Quality and Compliance Across Your Organization Did you know that a pharmaceutical company can receive misdemeanor fines that go up to 500,000 dollars and criminal fines that go up much higher, for FDA violations? In addition, they could also face delayed product launches and reputational risks that can pose further financial disadvantages. Pharmaceutical […]
